July 17, 2024Open Access

Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Impact of frailty towards immunogenicity and reactogenicity of BNT162b2 boosters administered via intramuscular or intradermal routes in a Thai geriatric population DESIGN: Prospective, randomized, open-labeled.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Niyomnaitham et al. (Wed,) studied this question.

synapsesocial.com/papers/68e60005b6db64358759364d https://doi.org/https://doi.org/10.1016/j.jnha.2024.100315

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management2021 · 77 citations
2Epidemiology and Clinical Presentation of COVID-19 in Older Adults2022 · 57 citations
3Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines–Early experience with vaccine rollout in a multi-site healthcare system2022 · 18 citations
4Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources2020 · 886 citations
5Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses2019 · 152 citations

Me gusta

Guardar

Ver artículo completo